AI
Commented by André Will-Laudien on June 11th, 2025 | 07:10 CEST
Artificial intelligence predicts a perfect summer – 150% chance with Lufthansa, Credissential, TUI, and D-Wave
It is worth taking a closer look - even if many might blink in disbelief. Despite ongoing geopolitical tensions and a sluggish economy, the DAX 40 index has already surged by 20% in 2025. Investors are clearly no longer allowing themselves to be rattled by tariff threats and bleak headlines because no one wants to be without stocks anymore. Artificial intelligence is now even available as investment advice, which also recommends a healthy diversification across all asset classes, sectors, and countries around the world in order to generate at least 5% per annum. Yes, 5% - that is the ideal scenario for people who already have substantial capital. Risk-aware and even speculative investors would like to see a little more. Summer is approaching – typically a slow season – but AI is predicting temperatures in Germany at times exceeding 40 degrees Celsius. We take a look at stocks that are already in a hot phase.
Read
Commented by Stefan Feulner on June 10th, 2025 | 07:05 CEST
Palantir, NetraMark, Qualcomm – Caution, buy signals!
Artificial intelligence is fundamentally changing the economy. It optimizes processes, reduces costs, and creates new business models. Its use in the healthcare and pharmaceutical sectors is currently developing particularly dynamically. Data-based decisions and personalized medicine are significantly increasing efficiency. According to experts, the global market for AI in healthcare could grow disproportionately in the coming years. Many AI companies are still in the early stages of their development.
Read
Commented by Fabian Lorenz on June 3rd, 2025 | 07:20 CEST
A bombshell and a buying opportunity! BioNTech, Bayer, and AI stock NetraMark
Bombshell news from BioNTech. The Company has announced a collaboration for its cancer pipeline - billions in revenue are on the horizon. The stock has surged significantly. Are there other exciting buying opportunities in the biotech and pharma sectors right now? US politics have recently dampened industry sentiment. The Trump administration wants to lower drug prices. One potential beneficiary is NetraMark, as this AI gem helps industry cut development costs and timelines. In addition, takeover speculation could drive the stock in the second half of the year. And what is Bayer doing? The stock has outperformed the DAX in 2025. Are there reasons to consider buying?
Read
Commented by Nico Popp on June 3rd, 2025 | 07:00 CEST
Get more out of your money! Scaling is happening here: Apple, Credissential, and Shopify
For years, banks have controlled how we manage our money. The structures surrounding payment flows and investments are still quite rigid. But the old structures are breaking up and offering new potential - for digitally savvy users and investors alike. We show you what is happening in fintech and e-commerce and how investors can benefit.
Read
Commented by Stefan Feulner on June 2nd, 2025 | 07:00 CEST
Rheinmetall, Volatus Aerospace, C3.ai – Upgrades and explosive results
The quarterly reporting season is drawing to a close, with chip giant Nvidia being the last of the Magnificent 7 stocks to present its figures. Analysts' ambitious targets were once again smashed, but uncertainties surrounding the trade war between China and the US are dampening the outlook for the industry leader. In contrast, uncertainty about the geopolitical situation continues to boost business for defense companies, which are receiving ever-higher price targets from analysts.
Read
Commented by Nico Popp on May 29th, 2025 | 07:00 CEST
The next AI revolution is being spearheaded by these hidden champions: Palantir, NetraMark, Roche
Are you still working the same way you did five years ago? Let's be honest: AI has changed a lot. The opportunities are enormous, especially in biotechnology. Already in 2024, one in four venture capital dollars for AI projects went to the healthcare sector, according to Silicon Valley Bank. Although around 80% of the industry already works with AI, there is a wide range of applications, with significant differences between experiments and groundbreaking innovations. We present three AI beneficiaries from the healthcare sector and explain how investors can profit.
Read
Commented by Armin Schulz on May 28th, 2025 | 07:00 CEST
Volatus Aerospace – A key player in the booming drone market
Global conflicts are currently drawing attention to drone technology, yet its civilian potential is often underestimated. Whether in industry, logistics, or environmental projects, unmanned systems are fundamentally changing work processes. Volatus Aerospace, based in Canada, operates strategically as a dual-use provider, combining commercial and security applications. Following a comprehensive restructuring through 2024, the Company could emerge as a hidden champion in this billion-dollar market - driven by strategic partnerships and regulatory adjustments.
Read
Commented by André Will-Laudien on May 27th, 2025 | 07:15 CEST
Up to 1500% with high tech and artificial intelligence – Incredible price movements at Evotec, NetraMark Holdings, and D-Wave
Artificial intelligence can now be found in all sectors of the economy. Search processes, validations, and historical comparisons now take place in a matter of seconds, and a dramatic leap in productivity is on the horizon. The capital markets have set themselves the task of evaluating these future processes. This is no easy task, as most topics cannot be viewed in isolation. Last week, renewed tariff threats led to a short-term price correction. These losses had to be offset yesterday, with political denials from the US sending share prices skyrocketing again. Under intense pressure, investors now have to decide whether investments promise short- or medium-term success. We use three examples to show how challenging this has become. Where are the opportunities and risks?
Read
Commented by Armin Schulz on May 22nd, 2025 | 07:10 CEST
Overlooked gems? Why artificial intelligence will catapult Novo Nordisk, NetraMark, and UnitedHealth to the forefront
The pharmaceutical industry is undergoing a historic transformation. Artificial intelligence is compressing drug development times from decades to months, reducing costs by billions, and unlocking therapies for previously untreatable diseases. Algorithms sift through genome data, simulate drug candidates, and optimize clinical trials with a precision that surpasses that of human researchers. This disruption is not only creating medical milestones but also lucrative opportunities for investors. Today, we look at three candidates and analyze the current situation at Novo Nordisk, NetraMark Holdings, and UnitedHealth.
Read
Commented by Armin Schulz on May 21st, 2025 | 07:05 CEST
Disruptive thinking, maximum profit: Why Super Micro Computer, MiMedia Holdings, and Xiaomi will boom in 2025
2025 is the year of disruptive pioneers: While AI is not only optimizing processes but also radically transforming industries, companies are focusing on business models that break old rules. It is not adaptation that counts here, but destruction, of monopolized markets, outdated supply chains, and rigid customer expectations. Three players stand out: a server innovator revolutionizing data centers; a cloud pioneer redefining the user experience; and a tech giant linking consumer goods with AI ecosystems. Their strategies? Scalability, platform power, and cross-industry solutions. Super Micro Computer, MiMedia Holdings, and Xiaomi show that disruption not only creates value, but it also dictates the rules of the game.
Read